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Abstract. It is needed for evidence-based medicine to support a med-
ical expert in discovering clinically useful knowledge with data mining
techniques. However, the real data on medical test results are severely in-
tractable since they are sequential, large-scale, and ill-deﬁned with many
attributes and missing values. This paper discusses how pre-processing
should be going and how a rule discovery support system should be
developed and actually discovers medically interesting rules from the
dataset on chronic hepatitis diagnosis. We have done the following pre-
processing: unifying diﬀerent names to the same entities, unifying diﬀer-
ent inspection cycle, discretizing time-series, and so on. Taking a general
framework of time-series data mining based on pattern extraction and
decision tree, we have discovered the rules consisted of the combination of
medical test result patterns. The system has discovered medically inter-
esting rules, and a medical expert has polished up the knowledge inspired
by them through the iteration of rule discovery and evaluation.
1 Introduction
Evidence-Based Medicine (EBM) is a medical practice method based on clinical
evidence from systematic research. The concern with the relation between data
mining and EBM has been growing for the last several years. However, there are
severe problems for medical data mining: the datasets obtained in daily clinics are
sequential, large-scale, and ill-deﬁned and need special complex pre-processing
[18,2].
Conventional work on pre-processing in the ﬁeld of data mining mainly
focuses on domain-independent methodology such as feature selection [8,7].2 Miho Ohsaki et al.
Domain-speciﬁc pre-processing, which strongly eﬀects on mining performance,
is frequently conducted by trial and error in practice, especially medical data
mining [10]. We should systematically establish the methodology to apply data
mining techniques to real medical datasets and should develop the software envi-
ronment to support medical experts in discovering medical knowledge for EBM.
Therefore, taking sequential data of medical test results on chronic hepatitis,
we discuss the concrete methods of pre-processing, develop a rule discovery sup-
port system that is speciﬁc to sequential data, and ﬁnally discover interesting
rules for medical experts [11]. Section 2 notes the basic concept and the develop-
ment of our rule discovery support system. Section 3 discusses the pre-processing
method for a medical dataset. Section 4 shows the result of applying the sys-
tem to the chronic hepatitis dataset. Finally, Section 5 concludes this paper and
notes the future work.
2 System Development
2.1 Conventional Rule Discovery from Time Series
It is most important for EBM to objectively predict future symptom based on
medical test results obtained for a certain term. Symptom changes at every mo-
ment, and diagnosis is conducted continually or intermittently. Many diagnosis
data are numerical rather than symbolic. Therefore, the data mining technique
to discover prediction rules from sequential and numerical data is suitable for a
real medical dataset. Here, we discuss the framework used in this research for
rule discovery from time series.
There are two general methods to deal with numerical time sequences in
machine learning. In one method, from a sequentialdata, we extractfeatures such
as frequency, distribution, and so on and regard them as attributes and a class. In
the other method, we regard the symbol given to a typical pattern extracted from
a sequence as attributes and a class. The former method has several problems:
rule readability is low due to the indirect expression of a sequence, features
depend on the kind of datasets, and attribute dimension considerably increases.
On the other hand, the latter method has many advantages: the rules with
visualized patterns are easy to intuitively understand, and we can control the
abstraction degree depending on the number of patterns. We then adopted the
latter pattern-based method.
Although there is a lot of work on pattern-basedtime-series data mining, their
mining frameworks are basically the same, which is based on the combination of
pattern extraction and classiﬁcation [3,14,15]. This general framework is shown
in the left side of Figure 1. We used it for our system.
Subsequences are cut out from sequential data with a sliding window and
representative patterns are extracted from the subsequences by clustering. Next,
these patterns are regarded as attributes and classes, and the rules are discovered
by a data mining scheme. Finally, the obtained rules are visualized as graph-
based rules, namely the pattern combinations plotted on a graph.Rule Discovery from a Chronic Hepatitis Dataset 3
Fig.1. General time series data mining framework based on pattern extraction and
classiﬁcation.
The details on the discretization process are shown in the right side of Figure
1. It consists of two phases: subsequence extraction and conversion into patterns
by clustering. On the ﬁrst phase, a subsequence s  =( xi,...,x i+w−1)i sc u t
out from a time sequence s =( x1,...,x n) by sliding a window of w-width at 1
sliding step.
A clustering method is used to form representative patterns on the second
phase. We note on K-means algorithm [5] that was used as a pattern extraction
method in [3]. It generates k clusters consisting of subsequences, where k is given
by a user. The center of a cluster is regarded as the representative pattern of
subsequences in the cluster.
Once symbols are given to these representative patterns and are regarded as
attributes and classes, popular data mining schemes for symbolic data can be
smoothly applied. For example, Das et al. [3] used association rule as a data
mining scheme and obtained rules in a format such as “If A1 and A2 and ... Ah
occur within V units of time, then B occurs within time T.”
2.2 System Design and Development
We designed and developed a rule discovery support system for sequential med-
ical data based on the general time-series mining framework. The design of our
system is shown in Figure 2. The system consists of two major components:
pre-processing with two levels and domain knowledge feedback from a medical
expert to the system.
Generally speaking, a clinical dataset includes many kinds of medical tests,
notation ﬂuctuation, both of numerical and symbolic values, both of routine and
thorough tests, various test cycles, and missing values. We then conducted the
pre-processing at a low level that depends on medical domain knowledge and
one at high level that does not depend as shown in Figure 2. We will explain the4 Miho Ohsaki et al.
Fig.2. Proposed rule discovery support system for sequential medical data.
details on each processing part after the explanation of the dataset used in this
research.
Instead of obtaining rules with high accuracy in a batch of data mining, the
system aimed to polish up rules to make them practical and beneﬁcial through
iterative interaction processes. The discovered rules inspire a medical expert,
and the expert returns his/her new knowledge to the system. This approach is
essential to discover really interesting rules for the target domain [9,1,10], espe-
cially for medicine [2]. Actually, we have developed and applied a rule discovery
system using general time-series mining framework to the same chronic hepatitis
dataset in our previous research [11,19]. We get here from the research, using
the comments on the previously obtained rules by a medical expert.
In the previous research, we used EM algorithm [4] as a clustering method
and C4.5 [16] as a data mining scheme and obtained domain knowledge that
GPT, one of diagnostic samplings, is the main measure to observe the condition
of chronic hepatitis. We then discovered the rules that predict the future trend
of GPT using currently stocked data of various medical tests with our developed
system. Figure 3 shows an example of the rules. A medical expert told us that
this rule was interesting and said as follows: It implies that GPT has a cyclic
change and may become a new discovery, since the conventional common sense of
medical experts was that GPT decreases in a monotone in spite of slight change.
This research aimed to discover rules to predict the future trend of GPT in
the same way of the previous research. To conﬁrm the hypothesis that GPT has
a cyclic change, we extended an observation term and investigated GPT’s long-
term trend. We used K-means algorithm [5] as a clustering method and C5.0, a
commercial version of C4.5 [16], as a data mining scheme.Rule Discovery from a Chronic Hepatitis Dataset 5
Fig.3. An example of rules discovered in our previous research on the same chronic
hepatitis dataset as in this research.
3 Pre-processing for Sequential Medical Data
3.1 Dataset Outline
We used a dataset of medical test results of B and C hepatitis patients that was
provided from Chiba university hospital. It was open as the common dataset of
a data mining contest [17]. Although it includes the data on chronic and acute
hepatitis, we focused on chronic hepatitis, since it is more necessary to grasp
and predict the symptom of chronic hepatitis is rather than acute hepatitis.
The raw dataset consisted of ﬁve sets of medical test items: patient proﬁle,
diagnostic sampling meta-data, the results of diagnostic sampling, the results of
liver biopsy, and the conditions of interferon medication. It includes 957 kinds
of medical tests, 771 patients, and about 1,600,000 records. The details on each
set of medical test items are as follows.
Patient Proﬁle
Patient proﬁle consists of identiﬁer, sex, and birth date of a patient. Patient
identiﬁer was used to extract the subsequence of medical test results for each
patient. Sex and age calculated with birth date were used as attributes to ﬁnd
out rules such as “If sex is female and age is greater than 50 and ..., then ...”
Diagnostic Sampling Meta-data
Diagnostic sampling is a generic term of blood and urine tests. Diagnostic sam-
pling meta-data was not directly used in our data mining scheme, since it was
the explanation on diagnostic sampling items.
Results of Diagnostic Sampling
Results of diagnostic sampling, the majority of data in our dataset, consist of
many numerical values of test results and a few sentences to comment on them
including patient identiﬁer, the date of a test, measure unit, and so on. GPT,
which was a class in our research, was one of diagnostic sampling. Patient iden-
tiﬁer and the date of a test were used to extract the subsequence of a diagnostic6 Miho Ohsaki et al.
sampling result for each patient. There are two kinds of diagnostic samplings:
frequently conducted routine tests and rarely conducted thorough tests.
Results of Liver Biopsy
Liver biopsy is a test to examine liver damage using a small piece of liver tissue
surgically took out. A medical expert judges the condition of liver by looking at
the piece using a microscope and gives symbolic value such as ’ﬁbrosis’ as a liver
biopsy result. The data on liver biopsy also included patient identiﬁer, the date
of a test, and virus type.
Liver biopsy has problems that it is rarely conducted due to heavy burden on
a patient and that it is uneven due to subjective judgment. However, it has an
advantage that it shows the progress of sickness more directly and clearly than
routine tests do.
Conditions of Interferon Medication
Interferon is a speciﬁc medicine for hepatitis caused by virus. Conditions of In-
terferon medication consist of patient identiﬁer, the date to start and to stop
medication, and the number of medications. Although this conditions were es-
sential to know the eﬀect of medical treatment by medicine, the data on the
internal interferon quantity were not included in our dataset.
Here, we discuss on whether these sets of medical test items of hepatitis are
common to that of other diseases. Generally speaking, patient proﬁle, diagnostic
sampling meta-data, and diagnostic sampling results are included in any sets
of medical test items. Although liver biopsy itself is not conducted to inspect
other diseases, similar tests that are rarely conducted but important exist for
them. Interferon is a speciﬁc medicine for hepatitis and not common to the
other disease. However, there are speciﬁc medicines for them. Therefore, the
explanation on our sets of medical test items will be useful to deal with that of
other diseases.
3.2 Low Level Pre-processing
We conducted data cleansing, item selection, test interval uniﬁcation, and miss-
ing value interpolation as a low level pre-processing that depended on medical
domain knowledge.
Data Cleansing
Before getting into the data cleansing to unify notation ﬂuctuation, we removed
diagnostic sampling meta-data, which only explain diagnostic sampling items,
among ﬁve sets of medical test items mentioned in Subsection 3.1. In addition,
we removed the data on acute hepatitis, because this research focused on chronic
hepatitis.
The target dataset included noises such as diﬀerent notation of the same
medical test results, that of the same eras, and symbolic values that should be
numerical values. Therefore, we modiﬁed and uniﬁed them based on domain
knowledge on the name and the notation of medical test results that was given
from technical books and experts on hepatitis. For example, symbolic valuesRule Discovery from a Chronic Hepatitis Dataset 7
such as negative and positive or − and + were converted into numerical values,
−1a n d+ 1 .
In fact, we conducted one of data cleansing, uniﬁcation of notation ﬂuctua-
tion, after the discretization by pattern extraction mentioned in Subsection 3.3.
The reason why we did data cleansing later was that the pattern extraction au-
tomatically reduced the huge number of medical test items to be uniﬁed. This
expertise will be practical for other medical datasets.
Item Selection
The number of medical test items, 930, was still huge even if the diagnostic
sampling meta-data and the data of acute hepatitis were removed, and there
were many items whose occurrence frequencies were too low to show their se-
quential trends. To avoid bad inﬂuence on the learning of a data mining scheme
from redundant attributes, we removed results of liver biopsy and conditions of
interferon medication as rare medical test items.
Test Interval Uniﬁcation and Missing Value Interpolation
Here, we explain the both of test interval uniﬁcation and missing value inter-
polation, because the interpolation was conducted for test interval uniﬁcation.
Generalization of a sequence needs instance sampling with a regular interval.
We then investigated the proper sampling interval for all medical tests and con-
ducted merging and interpolating data in time series to keep the regular interval.
Figure 4 shows the histogram of the number of medical test items for each
sampling interval to ﬁnd out a proper sampling interval. We adopted 28 days
interval, since the number of medical test items was the largest in the sampling
interval range from equal or more than 28 days to less than 56 days.
Fig.4. The histogram of the number of medical test items for each sampling interval.
I nt h ec a s eo ft h es a m p l i n gi n t e r v a ll e s s than 28 days, we merged all samples
in the interval, namely all medical test results in 28 days were merged into one
sample by averaging. In the case of the sampling interval more than 28 days, we
ﬁlled in the blank with the average of two samples before and after the blank as
a new interpolated sample.8 Miho Ohsaki et al.
The interpolation using long interval samples reduces data accuracy. There-
fore, we did not interpolate a sample for the samples with an interval more than
three months and divided the sequence into two sequences in such a case. We
also removed medical test items that had the number of occurrence equal or less
than 30 in ﬁve years.
3.3 High Level Pre-processing
We conducted discretization and data integration as a high level pre-processing
that did not depend on medical domain knowledge.
Discretization
We cut out the subsequence of medical test results for each patient from the
dataset using the framework mentioned in Subsection 2.1. The window size was
ﬁve years since ﬁve years observation is needed to grasp the trend of chronic
hepatitis at least. The sliding step of the window was the half of the window size
not to generate slightly diﬀerent subsequences.
Consequently, the subsequence extraction removed the data of patients whose
medical test terms were less than ﬁve years. In addition, we removed the data
of medical test items with less than two years term that were included in the
subsequences. We then reduced the number of patients from 771 to 448, that
of medical test items from 930 to 80, and that of records from 1,600,000 to
1,230,000.
Representative patterns were extracted from subsequences by clustering us-
ing K-means algorithm. To generate proper clusters, we randomly decided the
number of clusters from two to eight. We then selected a set of clusters based on
the two criteria: whether each cluster included at least ten instances and whether
the distances among clusters were large enough. The former criterion was de-
termined with the knowledge that the lower limit number of cases to conﬁrm
generality and reliability is ten at a viewpoint of medical science.
Data Integration
Finally, a new dataset consisted of ﬁve years subsequences were generated by
putting together the discretized numerical sequential data and the symbolic data
such as the name and the date of a medical test. We adopted the ﬁve years
patterns of diagnostic sampling results as attributes: the patterns of blood test
results and that of urine test results. We adopted the six months pattern of GPT
that is the important measure of chronic hepatitis prognosis as a class.
4 A Case Study
4.1 Experiment
We did a case study, applying the developed rule discovery support system (See
Section 2) to the pre-processed dataset of chronic hepatitis (See Section 3). We
then obtained 33 rules, selected 21 rules from them using the practical domainRule Discovery from a Chronic Hepatitis Dataset 9
knowledge that the threshold of abnormal GPT value is over 100, and showed
these rules to a medical expert as plotted graphs.
The expert gave us his comments on three rules; two rules were judged valu-
able and one rule was judged strange. In Figure 5, 6, and 7, the horizontal axis
and the vertical axis mean month and the value of a medical test result, respec-
tively. The graphs explain what GPT pattern will be brought out in the future
six months by the patterns of medical test results in the past 60 months.
Rule 1 and 2: Rules judged valuable
Rule 1, which was valued highly by the expert, is shown in Figure 5. Refer the
rule discovered in our previous research shown in Figure 3 before discussing
on this rule. The previously obtained rule describes the change of GPT in the
observation term from past 24 months to future 12 months. This rule inspired an
expert to notice the possibility of GPT’s cyclic change, and the expert said that
GPT’s cyclic change will be a signiﬁcant discovery for the research on chronic
hepatitis if it is proved.
Fig.5. Rule 1, which was judged valuable by a medical expert.
Therefore, we tried to verify the hypothesis that GPT changes periodically
and that its cycle is about three years by extending the observation term. The
GPT observed from past 60 months to future 6 months in Figure 5 globally
changes two times. Our hypothesis was more strongly supported by this result
than the previous result did.
Rule 2 shown in Figure 6 was also valued highly by the expert. It has the
similar trend to that of Rule 1 and supports our hypothesis, namely the change
of GPT with three years cycle.
Rule 3: A rule judged strange
Rule 3 shown in Figure 7 was strange for the medical expert. Although this
rule describes that GOT increases after GPT reduced, this trend contradicts the
domain knowledge on the relation between GPT and GOT. The expert explained
that GPT and GOT must change in synchronization with each other, since they
are similar liver enzymes.10 Miho Ohsaki et al.
Fig.6. Rule 2, which was judged valuable by a medical expert.
We then compared the raw data and the pattern for GPT and GOT and
found that the discrepancy between the raw data and the pattern for the both
of GPT and GOT was too large in Rule 3. The patterns in Rule 3 were not
representative and not proper to reﬂect actual data. On the other hand, the
discrepancy in Rule 1 and Rule 2 was small enough.
It is a severe problem that clustering dose not work well and generates wrong
patterns for pattern-based time-series mining [3,14,15]. Although we tried to
generate proper clusters by controlling the number of patterns and that of in-
stances in each pattern, that was not enough.
Fig.7. Rule 3, which was judged strange by a medical expert.
4.2 Discussion
On our pre-processing, we can say that it was proper for the sequential data of
medical test results on chronic hepatitis since we actually discovered interesting
rules with the pre-processed dataset, and a medical expert conﬁrmed that theRule Discovery from a Chronic Hepatitis Dataset 11
pre-processing methods and parameter setup were proper. The dataset used
in this study included many common test results for other kinds of disease.
Therefore, our pre-processing will work well for other clinical datasets.
On our system, it was eﬀective to discover medically interesting rules with
supporting that a medical expert makes and conﬁrms a hypothesis. However,
there was an incorrect rule caused by the discrepancy between a representative
pattern and raw subsequences. We think that we can solve this problem to reduce
the discrepancy by increasing the number and the granularity of representative
patterns.
There is some work to imply the problem of a general framework of time-series
data mining; similar trivial patterns frequently appear in many subsequences if
they are cut out from original time series with a sliding window [12,13]. In order
to make the inﬂuence least and to increase the number of available subsequences,
we set the sliding window step to the half of the window length. This experimen-
tal parameter worked well due to the variety of representative patterns obtained
from subsequences.
We manually conducted the readjustment of the system conditions based
on the knowledge feedback from a medical expert to polish up rules. We will
implement the semi-automatic interactive functions to our system. The medical
expert who evaluated our rules had the comment on that he frequently wanted
to examine whether similar rules come up or not in the case that some attributes
would be missing in a given dataset. This comment may be useful for our future
work.
5 Conclusions
For real medical data that are sequential, numerical, and ill-deﬁned, we discussed
pre-processing methods and developed a rule discovery support system. We ap-
plied our system to a dataset of medical test results for chronic hepatitis and
obtained pattern combination rules.
The current rules strengthened the reliability of the hypothesis that GPT
changes with three years cycle, which was formulated in our previous research.
A medical expert said that the rules were worth of evaluating since they were
diﬀerent from the common sense in medical science and could be a new discovery.
Therefore, we conclude that our pre-processing method, developed system, and
knowledge feedback from an expert to the system were eﬀective. We expect that
our methodology is applied to other medical datasets.
We are going to continue this research to solve the remained issues: reduc-
ing the discrepancy between a representative pattern and raw subsequences,
facilitating semi-automatic interaction with a medical expert, and justifying the
discovered interesting rules on the cyclic change of GPT.
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